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A HYBRID MULTISCALE MODEL FOR CANCER INVASION OF
THE EXTRACELLULAR MATRIX\ast 
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Abstract. The ability to locally degrade the extracellular matrix (ECM) and interact with
the tumor microenvironment is a key process distinguishing cancer cells from normal cells, and
is a critical step in the metastatic spread of the tumor. The invasion of the surrounding tissue
involves the coordinated action of the cancer cells, the ECM, the matrix degrading enzymes, and
the epithelial-to-mesenchymal transition. In this paper, we present a mathematical model which
describes the transition from an epithelial invasion strategy of the epithelial-like cells (ECs) to an
individual invasion strategy for the mesenchymal-like cells (MCs). We achieve this by formulating
a genuinely multiscale and hybrid system consisting of partial and stochastic differential equations
that describe the evolution of the ECs and the MCs while accounting for the transitions between
them. This approach allows one to reproduce, in a very natural way, fundamental qualitative features
of the current biomedical understanding of cancer invasion that are not easily captured by classical
modelling approaches, for example, the invasion of the ECM by self-generated gradients, and the
formation of EC invasion islands outside of the main body of the tumor.
Key words. cancer invasion, multiscale modelling, hybrid continuum-discrete, coupled partial
and stochastic partial differential equations
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1. Introduction. Identified as one of The Hallmarks of Cancer (Hanahan and
Weinberg (2000, 2011)), cancer invasion is a complex process involving numerous in-
teractions between the cancer cells and the extracellular matrix (ECM) (the tumor
microenvironment) facilitated by matrix degrading enzymes. By its nature, the inva-
sion involves the development and alteration of the cell-cell and cell-matrix adhesion
processes. Broadly speaking, during the progression to full malignancy, cancer cells
reduce their cell-cell adhesions and gain cell-matrix adhesions. Coupled with changes
in the cell migration and proliferation, this enables the local spread of cancer cells
into the surrounding tissue. Any encounter with blood or lymphatic vessels in the
tumor microenvironment initiates the spread of the cancer to secondary locations in
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Fig. 1. ``Diversity of cancer invasion."" Classification of the various migration and invasion
strategies and corresponding types of tumors. As the complexity of the tumor increases, so do the
expressions of cell-matrix and cell-adhesion molecules (integrins and cadherins) and the character-
ization of the invasion as individual or collective. Figure adopted from Friedl and Wolf (2003).
Fig. 2. ``Plasticity of cancer invasion."" The character of cancer cell migration changes from
collective to individual following the loss of the cadherin or \beta 1 integrin function. The corresponding
cellular transition programs are conditionally reversible, leading to metastases at later locations
within the organism. Figure from Friedl and Wolf (2003).
the host organism, i.e., metastasis (see Mehlen and Puisieux (2006), Weigelt, Peterse,
and van't Veer (2005)).
Having been studied in some detail for the past 15--20 years, it has become clear
that cancer invasion has a certain degree of diversity in its migratory mechanisms,
and of plasticity in cellular behavior and properties. The diversity of cancer invasion
mechanisms is illustrated schematically in Figure 1, and their behavioral plasticity in
Figure 2. Both types of invasions are extensively discussed in Friedl and Wolf (2003).
Subsequently, cancer invasion can be broadly classified into two main groups, differ-
ing in the behavior of how the cells migrate---individually or collectively---and how
these are controlled by different intracellular molecular programs. Accordingly, can-
cer invasion can be characterized as epithelial or collective invasion whereby clusters
or sheets of connected cells move en masse, or as mesenchymal or individual inva-
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sion whereby single cancer cells or small numbers of cancer cells actively invade the
microenvironment.
Cancer cells may transition back and forth between the two mechanisms during
the invasion process as they penetrate the surrounding tissue. The transition from ep-
ithelial to mesenchymal invasion is known as the epithelial-to-mesenchymal transition
(EMT), and the opposite as mesenchymal-to-epithelial transition (MET). Both the
EMT and MET processes are largely controlled by variations in the expression levels of
integrins, proteases, and cadherins, and varying cell-cell communication via gap junc-
tions. They are, moreover, induced by, e.g., the secreted transforming growth factor
beta (TGF-\beta ) and the epidermal growth factor (EGF) proteins. We refer the reader
to consult Thiery (2002), Roche (2018), Kalluri and Weinberg (2009), Te Boekhorst,
Preziosi, and Friedl (2016) and the references therein for detailed discussions on the
triggering of EMT, MET, and their properties and role in development and cancer.
An alternative invasion mechanism, known as amoeboid invasion, also exists,
whereby individual cells exhibit morphological plasticity and develop the ability to
squeeze through gaps in the ECM rather than modify/degrade the ECM via ma-
trix degrading enzymes, e.g., urokinase-type plasminogen activator (uPA) and matrix
degrading metalloproteases (MMPs) (see Madsen and Sahai (2010), Sabeh, Shimizu-
Hirota, and Weiss (2009)).
Cancer invasion has also been the focus of mathematical modelling over the
past twenty years or so, beginning with the work of Gatenby and Gawlinski (1996).
Since then, many different models and approaches have been formulated, some taking
an individual-based approach, e.g., Ramis-Conde et al. (2008a,b), Hatzikirou et al.
(2010), Wang et al. (2013), Schl\"uter, Ramis-Conde, and Chaplain (2015), others
adopting a continuum approach using systems of partial differential equations, e.g.,
Chaplain and Orme (1996), Preziosi (2003), Chaplain and Lolas (2005, 2006), An-
dasari et al. (2011), Domschke et al. (2014a), Deakin and Chaplain (2013), Painter
and Hillen (2013), Kolbe et al. (2016), Sfakianakis et al. (2017), Engwer, Stinner, and
Surulescu (2017), Peng et al. (2017), while others have adopted a hybrid continuum-
discrete approach, e.g., Anderson et al. (2000), Anderson (2005), Colombi, Scianna,
and Preziosi (2017). An individual-based approach has the advantage of being able to
focus on single cells, to account for cellular processes in detail, and is more accurate
at smaller scales and smaller cell numbers. On the other hand, the averaging of the
microscale dynamics that takes place in the continuum approach has the advantage of
being able to capture macroscopic processes and efficiently model large scales without
having to resort to high performance computing. Moreover, the continuum approach
has the added benefit of allowing for mathematical analysis of the developed models.
In the current paper, we apply a multiscale modelling framework to cancer inva-
sion that explicitly incorporates the transition from epithelial to individual invasion
and vice versa. In particular, we describe the epithelial-like cancer cells (ECs) through
a density distribution, and their spatiotemporal evolution by a macroscopic determin-
istic model. On the other hand, the mesenchymal-like cancer cells (MCs) are modelled
by an atomistic approach, and their spatiotemporal evolution by an individual sto-
chastic model. This is a genuinely hybrid approach where we explicitly include the
EMT and MET processes between the two cancer cell types and their corresponding
discrete and continuum descriptions.
Previous approaches in the literature of a similar modelling philosophy and sci-
entific focus are not many. We refer, for instance, to the works of Colombi et al.
(2015a,b), where the authors employ a measure theoretic approach to study cell dif-
ferentiation and aggregation, to Colombi, Scianna, and Preziosi (2017), in which a
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biological and mathematical ``switch"" between a concentrated cell-particle description
and the corresponding distributed mass approach is studied, to Capasso and Morale
(2010), where a ``doubly stochastic"" system of interacting cell-particles is studied
leading, in the large cell-particle limit, to deterministic partial differential equations
(PDEs), to Hiremath and Surulescu (2016a), Hiremath et al. (2018), Colombi and
Scianna (2017), where coupled PDE-SDE (stochastic differential equations) systems
describing biological processes at population, cellular, and subcellular scales are stud-
ied, and to Ca\~nizo, Carrillo, and Patacchini (2015), Carrillo, Colombi, and Scianna
(2018), where continuum models of (energy) interacting cell-particles are studied, and
the existence of global minimizers is established.
2. Model derivation. The modelling framework that we propose is a genuinely
hybrid combination of the two cancer cell types, ECs and MCs, described by a contin-
uum density and a collection of discrete cells. For the sake of clarity of presentation,
the development of the model and the corresponding techniques are constrained to
the (spatial) two-dimensional case.
Therefore, our paper is structured as follows. In section 2.1 we describe the
continuum density submodel of the problem. This is a macroscopic deterministic
model that addresses the spatiotemporal evolution of the densities of the ECs, ECM,
and the MMPs. In this submodel, the MCs participate only implicitly, i.e., they
influence the ECs and the rest of the components of the submodel, but their time
evolution is not dictated by it. We then introduce the discrete cell-particle submodel
of the problem in section 2.2. This submodel describes the time evolution of the MC
cells, including their biased random motion along the gradients of the ECM. It does
not include cell growth or proliferation, although they can be easily incorporated into
the model. The coupling between the continuum components (ECs, ECM, MMPs)
and the discrete (MCs) occurs in several places: The proliferation of the ECs, the
degradation of the ECM, the production of the MMPs, the haptotaxis of the MCs,
and most notably the transition between the ECs and MCs. In particular, in section
2.3 we describe the transitions between the density and cell-particle phases of the
cancer cells. We address the way the MC cells are ``substantiated"" from their density
formulation via a density-to-particle process, and how they transition back to density
via an opposite particle-to-density process. In section 2.4 we present the combined
spatiotemporal evolution of the two cancer cell types under the prism of the EMT
and MET processes.
2.1. Density formulation. From a macroscopic deterministic approach, we
follow the seminal works of Liotta, Saidel, and Kleinerman (1977), Gatenby and
Gawlinski (1996), Anderson et al. (2000), Byrne et al. (1999) and describe the ECs,
MMPs, and ECM by their densities. The MCs are primarily described as isolated
cell-particles; the model for their time evolution is derived in section 2.2. It should
be noted that the MCs also appear in the density formulation, as they directly affect
the ECs, MMPs, and the ECM. Since the focus of this paper is on the combination
of the two cancer cell phenotypes and their corresponding discrete and continuum
phases, rather than on the biological applications of the model, we incorporate only
the very basic biological processes. More detailed and cancer-type specific models will
be considered in follow-up works.
Indeed, we mainly assume that the ECs are transformed into MCs and vice-
versa via the MET and EMT processes, and that they proliferate by following a
logistic volume-filling constraint as they compete for free space and resources with
each other, the MCs, and the ECM. Furthermore, we assume that the ECs diffuse into
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the environment, although this process is expected to be very slow. This is included
in the model to capture, in a simplified and linear way, the effect of mechanical forces
exerted on the cells. More realistic assumptions of the diffusion can be considered
by accounting for the appropriate biological phenomena and extending the model
accordingly. The same holds true for the -taxis driven migration as well; extensions
of the model can account for a plethora of intra- and extracellular processes relevant
to the migration of cancer cells.
To proceed, we denote by \Omega \subset \BbbR 2 the Lipschitz domain of study, and by c\alpha (x, t),
c\beta (x, t), m(x, t), and v(x, t), x \in \Omega , t \geq 0 the densities of the ECs, MCs, MMPs, and
ECM respectively. From here onwards, we denote by superscripts \alpha and \beta the two
types of cancer cells, the ECs and MCs, respectively.
Based on the above discussions, we consider the following equation for the evolu-
tion of the ECs:
\partial 
\partial t
c\alpha (x, t) = D\alpha \Delta c
\alpha (x, t)\underbrace{}  \underbrace{}  
diffusion
 - \mu EMT\alpha (x, t)c\alpha (x, t)\underbrace{}  \underbrace{}  
EMT
+\mu MET\beta (x, t)c
\beta (x, t)\underbrace{}  \underbrace{}  
MET
+ \rho \alpha c c
\alpha (x, t)
\bigl( 
1 - c\alpha (x, t) - c\beta (x, t) - v(x, t)\bigr) \underbrace{}  \underbrace{}  
proliferation
,(2.1a)
where \mu EMT\alpha (x, t) = \mu \alpha \scrX \scrE (t)(x), \mu MET\beta (x, t) = \mu \beta \scrX \scrM (t)(x), with \scrE (t),\scrM (t) \subset \Omega , and
D\alpha , \mu \alpha , \mu \beta , \rho 
\alpha 
c \geq 0.
As previously noted, the MCs are described by their cell-particle formulation
---which we present in section 2.2---and the corresponding evolutionary equations.
The MCs participate in (2.1a) via their density c\beta after having undergone a specific
particle-to-density transformation; this is discussed in section 2.3.
Since the triggering mechanisms of EMT and MET are not the focus of this work,
we refrain from a detailed modelling. We instead assume a simplified approach where
EMT occurs in a randomly chosen subset of the domain \scrE (t) \subset \Omega in (2.1a). We
understand \scrE (t) as the union of a number of sets, each having the size of a single
biological cell; cf. (2.11) and section 2.3 for further discussion on the way that \scrE (t)
is formed. In a similar way, we assume that the MET occurs randomly at every cell-
particle, each giving rise to a domain the size of a biological cell, and their union to
the set \scrM (t); see also (2.16) and sections 2.2 and 2.3 for further details.
We also assume that both types of cancer cells, ECs and MCs, produce MMPs,
which in turn diffuse into the environment (molecular diffusion) and decay with a
constant rate, thus satisfying
(2.1b)
\partial 
\partial t
m(x, t) = Dm\Delta m(x, t)\underbrace{}  \underbrace{}  
diffusion
+ \rho \alpha mc
\alpha (x, t) + \rho \beta mc
\beta (x, t)\underbrace{}  \underbrace{}  
production
 - \lambda mm(x, t)\underbrace{}  \underbrace{}  
decay
,
with Dm, \rho 
\alpha 
m, \rho 
\beta 
m, \lambda m \geq 0 constants. Alternative approaches could also be consid-
ered, e.g., an ECM-density dependent production of the MMPs by the cancer cells.
We assume that the ECM is represented by the density of the collagen macro-
molecules, and is therefore modelled as a nonuniform, immovable component of the
system that neither diffuses nor otherwise translocates. Furthermore, we assume that
the ECM is degraded by the combined action of the cancer cells/MMPs complex. Fi-
nally, for the sake of simplicity, no reconstruction of the matrix is assumed. Overall,
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the evolution equation of the ECM is given by
(2.1c)
\partial 
\partial t
v(x, t) =  - \bigl( \lambda \alpha v c\alpha (x, t) + \lambda \beta v c\beta (x, t)\bigr) m(x, t)v(x, t)\underbrace{}  \underbrace{}  
degradation
,
with \lambda \alpha v , \lambda 
\beta 
v \geq 0 constants. We are motivated by Sabeh, Shimizu-Hirota, and Weiss
(2009) to model the matrix degradation in this particular way, i.e., dependent on
the complex cancer cells/MMPs instead of the MMPs alone. Possible extensions of
the model could include nondiffusible MMPs, MC-only matrix degradation, matrix
reconstruction, and other biologically relevant processes.
The (advection-)reaction-diffusion1 (A-)RD system (2.1a)--(2.1c) can also be writ-
ten in a more convenient matrix-vector compact form for the numerical treatment
formulation; see also Appendix A. In particular, using the notation
w(x, t) =
\bigl( 
c\alpha (x, t),m(x, t), v(x, t)
\bigr) T
,
(2.1a)--(2.1c) read
(2.2) wt(x, t) = D(w(x, t)) +R(w(x, t)),
where
SD(w) = \BbbD \Delta w and R(w) =
\left(   - \mu EMT\alpha c\alpha + \mu MET\beta c\beta + \rho \alpha c c\alpha \bigl( 1 - c\alpha  - c\beta  - v\bigr) \rho \alpha mc\alpha + \rho \beta mc\beta  - \lambda mm
 - \bigl( \lambda \alpha v c\alpha + \lambda \beta v c\beta \bigr) mv
\right)  ,
with \BbbD = diag(D\alpha , Dm, 0)T , denote the diffusion and reaction operators, respectively.
As noted previously, in the more general case where chemotaxis or haptotaxis are
considered, the corresponding formulation should also include an advection operator.
Clearly, cancer invasion models of the form (2.2) are mere simplifications of the
biological reality; they are also quite simple in their mathematical structure. Still,
their analytical and numerical investigations are challenging, depending on the actual
structure of the assumed model, whether, e.g., -taxis, nonlocal adhesion, or nonlinear
diffusion is included in (2.2). Indicatively, we refer to Hillen, Painter, and Winkler
(2017), Marciniak-Czochra and Ptashnyk (2010), Andasari et al. (2011), Giesselmann
et al. (2018), Stinner, Surulescu, and Uatay (2016), Kolbe et al. (2016), Marciniak-
Czochra, Karch, and Suzuki (2013), Winkler and Tao (2014) and the references therein
for a study of various cases of cancer invasion models. One of the reasons for this is
their mixed nature, i.e., the ECs and MMPs obey partial differential equations (PDEs)
with respect to time and space, whereas the ECM obeys an ordinary differential
equation (ODE) with respect to time for every point in space.
2.2. Particle formulation. We are motivated in this description by methods
and techniques that have been used previously in other scientific fields. One such
example is the classical particle-in-cell (PIC) method first proposed in Harlow (1965)
and used among others in plasma physics. A second example is the smoothed-particle
hydrodynamics (SPH) method used in astrophysics and ballistics; see, e.g., Gingold
and Monaghan (1977). The stochastic nature of the ODEs that the cell-particles
1In the general case, the ECs equation (2.1a) could include -taxis terms in the form of advection
as well.
830 N. SFAKIANAKIS, A. MADZVAMUSE, AND M. CHAPLAIN
obey is motivated by the seminal work of Stratonovich (1966). For the combination
of the two cancer cell formulations, we are inspired by Blanc, Le Bris, and Lions
(2007), Kitanidis (1994), Makridakis, Mitsoudis, and Rosakis (2014), Tompson and
Dougherty (1992).
In view of the above, we describe the MCs as a system of N cell-particles that are
indexed by p \in P = \{ 1, . . . , N\} and account for their positions xp(t) \in \BbbR 2 and masses
mp(t) \geq 0. We allow for their number to vary in time and so we set N = N(t) \in \BbbN .
The mass distribution of such a system of cell-particles, \{ (xp,mp), p \in P\} , is
given by
(2.3) \~\~c(x, t) =
\sum 
p\in P
mp(t)\delta (x - xp(t)),
where \delta (\cdot  - xp(t)) represents the Dirac distribution centred at xp \in \BbbR 2. Clearly (2.3)
is not a function, so we consider a kernel \zeta and redefine the mass distribution of the
cell-particles \{ (xp,mp), p \in P\} as
\~c(x, t) =
\int 
\Omega 
\~\~c(x\prime , t)\zeta (x - x\prime )dx\prime (2.3)=
\sum 
p\in P
mp(t)\zeta (x - xp(t)).(2.4)
The function \zeta need not be smooth; hence to simplify the rest of this work, we
choose the characteristic function of the rectangle K0 centered at the origin 0 \in \BbbR 2,
(2.5) \zeta (x) = \scrX K0(x), x \in \BbbR 2.
The choice of K0 (shape, size, and location) is justified in sections 2.2.1 and 3.
2.2.1. Interactions between cell-particles. We understand the cell-particles
as isolated cancer cells or cancer-cell aggregates of similar size and mass. To maintain
similar masses, we split and merge the cell-particles according to their mass and
position. In particular, when a cell-particle represents an isolated cancer cell, we set
mref to be the reference cell mass and K0 its (two-dimensional) footprint, and proceed
as follows:
Splitting. A cell-particle (xp,mp) with mass mp >
4
3 mref is split into two cell-
particles (x1p,m
1
p), (x
2
p,m
2
p) of the same position x
1
p = x
2
p = xp and mass
m1p = m
2
p =
1
2 mp. From that moment onwards, these two cell-particles are
considered different from each other.
Merging. A small cell-particle (xp,mp) with mass mp <
2
3 mref is merged with an-
other small cell-particle (xq,mq) if they are close to each other, i.e.,
\| xp  - xq\| < diam(K0),
where \| \cdot \| describes the two-dimensional Euclidean norm. The resulting cell-
particle is set to have the cumulative mass of the two cell-particles, and to be
located at their (intermediate) center of mass,
(2.6)
\biggl( 
mpxp +mqxq
mp +mq
,mp +mq
\biggr) 
.
If more than two small cell-particles are found within merging distance at the
same time, they are merged pairwise in the order they have been created.
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Given that the distance between the cell-particles is sufficiently small, itera-
tions of the merging and splitting processes lead to cell-particles with masses mp \in 
[ 23 mref,
4
3 mref], i.e., cell-particles with more-or-less the reference cell mass mref.
These two processes are primarily meant to deal with two particular biological
phenomena: the formation of MC-clusters and the cell growth and mitosis. Still,
as the focus of the current paper is more methodological, and since we respect a
go-or-grow dichotomy between the ECs and the MCs, we postpone the discussion of
the underlying biological procedures and the corresponding mathematical modelling
to a future work. Beyond the merging and splitting procedures, we do not consider
other processes that alter the masses of the cell-particles. We also do not consider
any further interactions between the cell-particles in this work (such as competition
for free space or development of collision forces) as we try to be consistent with the
dynamics that are usually assumed by macroscopic deterministic models similar to
(2.1a)--(2.1c). In effect, two or more cell-particles could occupy the same physical
position, in the same way as the local density of cancer cells can be large.
2.2.2. Time evolution of cell-particles. We assume that the cell-particles
perform a biased random motion that is comprised of two independent processes: a
directed-motion part that represents the haptotactic response of the cells to gradients
of the ECM-bound adhesion sites, and a random/stochastic-motion part that describes
the undirected kinesis of the cells as they sense the surrounding environment; we
understand this phenomenon as a Brownian motion. We reproduce this way, at the
cell-particle level, the diffusion and -taxis dynamics prescribed by the macroscopic
deterministic cancer invasion models; see, e.g., Anderson et al. (2000).
In a slightly more general framework, we assume that the cell-particles obey a
stochastic differential equation (SDE) of the (differential) form
(2.7a) dXpt = \mu (X
p
t , t) dt+ \sigma (X
p
t , t) dW
p
t for p \in P,
where Xpt represents the position vector of the cell-particles p \in P , and Wpt is a
Wiener process with independent components. Here, \mu and \sigma 2 are the drift and
diffusion coefficients that encode the modelling assumptions made on the directed
and random parts of the motion of the cell-particles. Their contribution in (2.7a)
can be understood as follows: During a short time period \delta t, the changes of the
stochastic process Xpt follow a normal distribution with expectation \mu (X
p
t , t) \delta t and
variance \sigma (Xpt , t)
2
\delta t. Further insight into (2.7a) can be heuristically derived from
the corresponding random equation,
(2.7b)
d
dt
Xpt = \mu (X
p
t , t) + \sigma (X
p
t , t) \xi 
p
t for p \in P,
where the integral of the noise \xi pt gives rise to the Wiener process W
p
t . The noise
\xi pt along with the intensity \sigma represents the fluctuations around the expected value
of the velocity \mu . In the current work, and primarily for the sake of simplicity, we
assume that \mu depends on the gradient of the ECM and \sigma is constant. If more
complex dynamics and, most notably, if interactions between the cell-particles and/or
the environment are assumed, \mu and \sigma should be adjusted accordingly.
We do not undertake an analysis of (2.7a) here. However, we note that it should
be performed over a complete probability space (\scrS ,\scrH ,\BbbP ) with a filtration \{ \scrH t\} t\geq 0.
The sample space \scrS can be seen as containing all cell-particles \omega belonging to one
particular tumor. Thus, for every p \in P , the position vector Xp : S \times [0,\infty ) \rightarrow \BbbR 2
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represents an appropriate stochastic process. For more details, we refer the reader to,
e.g., Oksendal (2003).
Furthermore, in the special cases \mu (x, t) = \alpha x and \sigma (x, t) = \beta , \alpha \in \BbbR , and
\beta \geq 0, the stochastic process that solves (2.7a) can be numerically approximated by
the corresponding half-step explicit Euler--Maruyama particle motion scheme,
(2.7c) Xpt+\tau = X
p
t + \alpha X
p
t \tau + \beta Z
p
\surd 
\tau for p \in P ,
with \tau > 0 being the timestep of the scheme, and Zp a vector of normally distributed
values of zero mean and unit variance; cf. Appendix B and Kloeden and Platen
(1992).
Although not the aim of the current work, we note that the many-particle limit
N \rightarrow \infty in (2.7a) is important as it allows one to recover the macroscopic deterministic
equation that the MCs would satisfy if the N \rightarrow \infty limit were relevant and justified.
In the special case of (2.7c) the N \rightarrow \infty limit would give rise to an advection-diffusion
equation for the corresponding densities, with constant diffusion coefficient 12\beta 
2 and
nonconstant advection speed \alpha x; see, e.g., Kitanidis (1994), Tompson and Dougherty
(1992), Stratonovich (1966). Conversely, if the diffusion coefficient of the macroscopic
equation is nonconstant as, e.g., in Engwer, Stinner, and Surulescu (2017), the corre-
sponding particle-motion scheme should read, instead of (2.7c), as
(2.8) Xpt+\tau = X
p
t +A(X
p
t )\tau +B(X
p
t ) \cdot Zp
\surd 
\tau for p \in P ,
with the advection operator
(2.9) A = v +\nabla \cdot D,
encoding the advection speed v of the macroscopic equation adjusted by a drift term
that involves the diffusion matrix D, and where
(2.10) B \cdot BT = 2D.
If v andD depend on the physical space, the It\^o-type correction of the advection speed
v in (2.9) is necessary so that the many-particle limit N \rightarrow \infty of (2.8) converges to the
correct macroscopic equation. We refer to Arnold (1974), Raviart (1986), Stratonovich
(1966), Tompson and Dougherty (1992), and Kitanidis (1994) for further discussions
and proofs of these claims.
Modelling reactions. Although the MCs participate in several reaction pro-
cesses (such as the EMT, MET, the proliferation of the ECs, the production of MMPs,
and the degradation of the ECM), the particle motion scheme (2.8) does not include
any reaction terms. We account for them in the following way.
Some of the MC cell-particles undergo MET to ECs and subsequently are trans-
formed into density via the particle-to-density operator that will be introduced in
section 2.3. These MCs are removed from the system of the MC cell-particles. The
new EC density is added to the existing one and participates normally in the system
(2.1a)--(2.1c). Conversely, a part of the EC density undergoes EMT towards MC, at
first as density, which is then transformed into cell-particles via a density-to-particle
operator, defined in section 2.3. These newly formed MCs are then added to the
system of the existing MC cell-particles.
We also note that within this framework, the modelling of cell-growth (increase of
cellular mass) and cell-mitosis is straightforward. Still, as we respect, in the current
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paper, a go-or-grow dichotomy between the ECs and MCs, we do not study these
processes any further.
Moreover, at every timestep of the method, the full distribution of MC cell-
particles is transformed temporarily into density (without undergoing MET to ECs)
via the particle-to-density operator. They participate then in the proliferation of the
ECs, the production of the MMPs, and the degradation on the ECM; cf. (2.1a)--(2.1c).
We give more details on the combination of the ECs and MCs in section 2.4.
2.3. Modelling phase transitions between cell-particles and densities.
In this section we describe the particle-to-density and the density-to-particle phase
transition operators.
We assume first that the domain \Omega is regular (e.g., rectangle in two-dimensions)
and large enough (on the order of 102--104 biological cells), to be uniformly partitioned
into equal rectangles/partition cells \{ Mi, i \in I\} ,
(2.11) \Omega =
\bigcup 
i\in I
Mi,
where every Mi is an affine translation of the generator cell K0. Note that K0 is the
same as the support of the characteristic function in (2.5). Clearly, | Mi| = | K0| =
K > 0.
Remark 2.1. More general domains \Omega can also be considered, possibly at the
expense of the equality of the Mis and the upcoming mass distribution relations
(2.16), (2.18). Note, moreover, that the partition cells Mi, i \in I do not coincide
with the discretization cells of the numerical method used to solve (2.1a)--(2.1c). The
latter constitute an instance of a sequence of computational grids of zero-converging
step sizes, whereas the former have a step size that represents physical properties of
biological cells and remains fixed over all computational grid resolutions.
Using the partitioning of \Omega to \{ Mi, i \in I\} , we represent a measurable c : \Omega \times 
(0,\infty )\rightarrow \BbbR by its simple-function decomposition,
(2.12)
\sum 
i\in I
ci(t)\scrX Mi(x),
where \scrX Mi is the characteristic function of the set Mi \subset \Omega , and ci(t) the mean value
of c(\cdot , t) over Mi,
(2.13) ci(t) =
1
K
\int 
Mi
c(x, t)dx.
Clearly, this representation conserves the mass of c(\cdot , t) over \Omega ,
(2.14)
\sum 
i\in I
Kci(t) =
\int 
\Omega 
c(x, t)dx.
On the other hand, a particle, indexed here by p \in P , can be represented either
by its position and mass (particle formulation),
(2.15) (xp(t), mp(t)) ,
or by the characteristic function with density value (density formulation),
(2.16)
mp(t)
K
\scrX Kp(x),
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whereKp is the affine translation of the generator cellK0 and is centred at xp. Clearly,
(2.16) implies that the mass mp of the particle is uniformly distributed over Kp.
Although the Kp, p \in P and the Mi, i \in I in (2.12) are equivalent up to affine
translations (to the K0), they do not, in general, coincide. The Mi, i \in I form a fixed
partition of the domain (cf. (2.11)), whereas the Kp, p \in P follows the position of
the cell-particles (2.16).
Based on the dual description (2.15) and (2.16) of the cell-particles, we set forth
the transition operators between cell-particles and densities.
2.3.1. Particles-to-density transition. Let \{ (xp(t),mp(t)), p \in P\} be a col-
lection of cell-particles. Using (2.4), we define the particle-to-density operator \scrF as
(2.17) \{ (xp(t),mp(t)), p \in P\} \scrF  - \rightarrow c(x, t).
To define the target function c(x, t), we go through all of the cell-particles, indexed
here by p \in P , and consider their corresponding density formulation (2.16). The
support Kp of the cell-particles overlaps with (possibly) several
2 of the partition cells
Mi, i \in I. In each of these partition cells, and in view of (2.16), we assign the
corresponding portion of the particle mass,
(2.18) mp
\bigm| \bigm| 
Mi
=
mp
K
\bigm| \bigm| Kp \cap Mi\bigm| \bigm| .
Due to the simple-function decomposition (2.12)--(2.13), we account for the contribu-
tion of all cell-particles p \in P to the partition cell Mi by
(2.19) ci(t) =
\sum 
p\in P
1
K
mp
\bigm| \bigm| 
Mi
(2.18)
=
\sum 
p\in P
mp(t)
K2
\bigm| \bigm| Kp \cap Mi\bigm| \bigm| for i \in I .
In view now of (2.12) and (2.19), we deduce the density function c(x, t) (as a
simple function) over the full domain \Omega as
(2.20) c(x, t) =
\sum 
i\in I
ci(t)\scrX Mi(x), x \in \Omega .
Refer to Figure 3 for a graphical representation of the particle-to-density operator \scrF 
in two dimensions.
2.3.2. Density-to-particles transition. Conversely, we define the density-to-
particle operator \scrB for a given density function c(x, t) by
(2.21) \{ (xp(t),mp(t)), p \in P\} \scrB \leftarrow  - c(x, t)
in the following way: In every partition cell Mi, i \in I, we assign one particle with
mass
(2.22) mi(t) =
\int 
Mi
c(x, t)dx
and position
(2.23) xi(t) = the (bary)center of Mi.
2Since the sets Kp, p \in P and Mi, i \in I are two-dimensional quadrilaterals of the same dimen-
sions, every Kp overlaps with at most five Mis.
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Fig. 3. Two-dimensional graphic representation of the particle-to-density operator \scrF . Left: We
consider a support Kp (p \in P ) around the location xp of every particle. The mass of every particle
mp (shown as points) is uniformly distributed over the respective support Kp. The grid represents
the partitioning of the domain. Right: A view from above reveals that the supports Kp can overlap
with several cells of the partition. The corresponding masses are assigned to the partition cells using
(2.19).
0
1
0.2
1
0.4
y
0.5
x
0.6
0.5
0 0
Fig. 4. Graphical representation of the density-to-particle operator \scrB . We compute the mass
mi of the density function c(x, t) (surface) over every partition cell Mi, i \in I (quadrilateral grid on
the xy plane) using (2.22). We then define the particle as (xi,mi), where the location xi is given
by (2.23).
For practical considerations, we set in the numerical simulations a minimum threshold
value on the densities, below which no transition to cell-particles takes place. This
threshold value is quite small and is used to avoid large numbers of cell-particles of
negligible mass. Refer to Figure 4 for a graphical representation of the density-to-
particles operator.
2.4. Coupling of the two cancer cell phenotypes and phases. We denote
again the two cancer cell phenotypes, EC and MC, by the superscripts \alpha and \beta ,
respectively, and consider for t \geq 0 the vector formulation (2.2) of the system (2.1a)--
(2.1c) with the density variables
w(x, t) = (c\alpha (x, t),m(x, t), v(x, t)) .
At the same physical time t, we write the MC cell-particles as
(2.24) \scrP \beta (t) = \bigl\{ \bigl( x\beta p (t),m\beta p\bigr) , p \in P (t)\bigr\} ,
and accordingly, the overall system is given by the tuple
(2.25)
\bigl( 
w(x, t),\scrP \beta (t)\bigr) , x \in \Omega , t \geq 0.
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In the evolution of the overall system, we consider the EMT and MET processes
separately from the rest of the dynamics of the system (2.1a)--(2.1c).3
2.4.1. EMT operator. The detailed modelling and biophysical accuracy of the
EMT triggering mechanism is not one of the main focal points of this work. Instead, we
assume a simplified approach whereby a randomly chosen part of the ECs (in density
formulation) c\alpha EMT undergoes EMT to give rise to MCs (still in density formulation),
c\alpha EMT
EMT -  -  - \rightarrow c\beta EMT.
The newly created MC density c\beta EMT is transformed into MC cell-particles via the
density-to-particle operator \scrB given in (2.21),
(2.26) c\beta EMT
\scrB  - \rightarrow \bigl\{ (x\beta p ,m\beta p ), p \in PEMT\bigr\} ,
where x\beta p , m
\beta 
p follow from (2.22), (2.23), and P
EMT is the corresponding set of in-
dices. Subsequently, the family of existing MC cell-particles is updated with the newly
created cell-particles. This is given by the disjoint union
(2.27)
\bigl\{ 
(x\beta p ,m
\beta 
p ), p \in P
\bigr\} \underbrace{}  \underbrace{}  
existing MC cells
\uplus \bigl\{ (x\beta p ,m\beta p ), p \in PEMT\bigr\} \underbrace{}  \underbrace{}  
newly created MC cells
=
\bigl\{ 
(x\beta p ,m
\beta 
p ), p \in P new
\bigr\} 
,
where P new is a re-enumeration of the multiset P \uplus PEMT.
Overall, combining the two cancer cell types, the EMT operator reads as
(2.28) \scrR EMT \bigl( c\alpha ,\bigl\{ \bigl( x\beta p ,m\beta p\bigr) , p \in P\bigr\} \bigr) = \bigl( c\alpha  - c\alpha EMT,\bigl\{ (x\beta p ,m\beta p ), p \in P new\bigr\} \bigr) .
2.4.2. MET operator. As with the EMT, the triggering mechanism of the
MET is not one of the focal points of this paper. We instead assume an approach,
where each of the MC cell-particles
\bigl\{ \bigl( 
x\beta p ,m
\beta 
p
\bigr) 
, p \in P\bigr\} undergoes MET to ECs ran-
domly,
(2.29)
\bigl\{ 
(x\beta p ,m
\beta 
p ), p \in P
\bigr\} MET -  -  - \rightarrow \bigl\{ (x\alpha p ,m\alpha p ), p \in PMET\bigr\} \underbrace{}  \underbrace{}  
newly created EC cells
.
The resulting EC cell-particles are instantaneously transformed to density via the
particle-to-density operator \scrF given in (2.17):
\bigl\{ 
(x\alpha p ,m
\alpha 
p ), p \in PMET
\bigr\} \scrF  - \rightarrow c\alpha MET.
In operator form, the MET reads
(2.30) \scrR MET \bigl( c\alpha ,\bigl\{ \bigl( x\beta p ,m\beta p\bigr) , p \in P\bigr\} \bigr) = \Bigl( c\alpha + c\alpha MET,\Bigl\{ (x\beta p ,m\beta p ), p \in \~P new\Bigr\} \Bigr) ,
where \~P new is a re-enumeration of the set difference P \setminus PMET.
3For ease of presentation and since the EMT and MET are assumed to be instantaneous and
tautochronous, we drop the dependence of the density variables and the cell-particles on x and/or t.
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2.5. Time evolution of the two cancer cell types. The evolution of the
ECs is controlled by (2.1a)--(2.1c) and through their coupling with the MCs cell-
particles by (2.7a). We study this combined system of PDEs and SDEs numerically,
while postponing any analytical investigations for a follow up work. To this end, we
consider the model (2.2) and set
Wn =
\Bigl\{ 
wn(i,j) =
\Bigl( 
cn(i,j),m
n
(i,j), v
n
(i,j)
\Bigr) 
, (i, j) \in Mx \times My
\Bigr\} 
,
\scrP \beta ,n =\bigl\{ \bigl( x\beta ,np ,m\beta p\bigr) , p \in Pn\bigr\} 
to denote numerical approximations of the density and particle variables w(x, t) and
\scrP \beta (t), respectively, at the instantaneous time t = tn. Here, Mx, My \in \BbbN denote the
resolution of the numerical grid along the x- and y-directions, respectively. We refer
to Appendix A for further information on the numerical method employed on W; we
focus here on the time evolution of the density and particle variables by means of
an operator splitting approach. In particular, for t \in [tn, tn+1], tn+1 = tn + \tau n, we
assume the following:
\bullet During the time period [tn, tn+ 12\tau n], the system evolves without the influence
of the EMT or MET as
(2.31a)
\bigl( 
Wn,\scrP \beta ,n\bigr)  - \rightarrow \Bigl( Wn+1/2,\scrP \beta ,n+1/2\Bigr) 
with
Wn+1/2 = \scrN [tn,tn+ 12 \tau n] \bigl( Wn,\scrP \beta ,n\bigr) ,(2.31b)
\scrP \beta ,n+1/2 =
\Bigl\{ \Bigl( 
x\beta ,n+1/2p ,m
\beta ,n+1/2
p
\Bigr) 
, p \in Pn+1/2
\Bigr\} 
,(2.31c)
where \scrN [t,t+\tau ] is the numerical solution operator responsible for the spa-
tiotemporal evolution of the system (2.1a)--(2.1c)---without EMT and MET.
Here, x
\beta ,n+1/2
p , p \in Pn, is given by the half-step Euler--Maruyama particle
motion scheme (2.8), rewritten here with respect to the local variables,
(2.32) X\beta ,n+1/2p = X
\beta ,n
p +A
\bigl( 
X\beta ,np
\bigr) \tau n
2
+B
\bigl( 
X\beta ,np
\bigr) \cdot Zp\sqrt{} \tau n
2
.
The number of cell-particles, their indices, and masses remain unchanged
during this step [tn, tn + 12\tau 
n], i.e.,
Pn+1/2 = Pn and m\beta ,n+1/2p = m
\beta ,n
p \forall p \in Pn.
Altogether, the combined evolution operators of the densities and cell-particles
read for this time period as
(2.33) \scrM 1
2 \tau 
n
\bigl( 
Wn, \scrP \beta ,n\bigr) = \Bigl( Wn+1/2, \scrP \beta ,n+1/2\Bigr) .
\bullet At t = tn + 12\tau n, the EMT and MET processes take place; they are assumed
to be instantaneous and tautochrone. They are represented by the \scrR EMT
and \scrR MET operators introduced in (2.28) and (2.30), respectively. For con-
sistency, we scale them by the time step \tau n and change their notation to
\scrR EMT\tau n and \scrR MET\tau n , respectively.
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In effect, the tuple
\bigl( 
Wn+1/2, \scrP \beta ,n+1/2\bigr) develops as
(2.34)
\Bigl( 
\~Wn+1/2, \~\scrP \beta ,n+1/2
\Bigr) 
= \scrR \tau n
\Bigl( 
Wn+1/2, \scrP \beta ,n+1/2
\Bigr) 
,
where \scrR \tau n denotes the parallel application of \scrR EMT\tau n and \scrR MET\tau n .4
\bullet During [tn + 12\tau n, tn+1], the densities and cell-particles evolve again without
the influence of EMT and MET as\Bigl( 
\~Wn+1/2, \~\scrP \beta ,n+1/2
\Bigr) 
 - \rightarrow \bigl( Wn+1, \scrP \beta ,n+1\bigr) ,
where, in a similar way as in [tn, tn + 12\tau 
n],
Wn+1 = \scrN [tn+ 12 \tau n,tn+1]
\Bigl( 
Wn+1/2, \~\scrP \beta ,n+1/2
\Bigr) 
,(2.35)
\scrP \beta ,n+1 = \bigl\{ \bigl( x\beta ,n+1p ,m\beta ,n+1p \bigr) , p \in Pn+1\bigr\} .(2.36)
Again, \scrN [tn+ 12 \tau n,tn+1] represents the numerical method for the solution of the
system (2.1a)--(2.1c),
Pn+1 = Pn+1/2 and m\beta ,n+1p = m
\beta ,n+1/2
p \forall p \in Pn+1.
In the above, x\beta ,n+1p , p \in Pn+1/2, is given by the half-step Euler--Maruyama
scheme (2.8),
(2.37) X\beta ,n+1p = X
\beta ,n+1/2
p +A
\Bigl( 
X\beta ,n+1/2p
\Bigr) \tau n
2
+B
\Bigl( 
X\beta ,n+1/2p
\Bigr) 
\cdot Zp
\sqrt{} 
\tau n
2
.
We combine the two evolution operators,
(2.38) \scrM \tau 
2
\Bigl( 
\~Wn+1/2, \~\scrP \beta ,n+1/2
\Bigr) 
=
\bigl( 
Wn+1, \scrP \beta ,n+1\bigr) .
Overall, using (2.33), (2.34), and (2.38), we can write the combined evolution
operator for the time period [tn, tn+1] as a splitting method of the form
(2.39)
\bigl( 
Wn+1, \scrP \beta ,n+1\bigr) =\scrM \tau n
2
\scrR \tau n \scrM \tau n
2
\bigl( 
Wn, \scrP \beta ,n\bigr) .
We close the system (2.39) with no-flux boundary conditions for the EC and MMP
densities, and reflective boundary conditions for the MCs cell-particles. The latter
should be understood as follows: Each particle that escapes the domain \Omega is returned
to its last position within the domain, and its new direction is chosen randomly. As
the ECM is modelled as an immovable part of the system, it does not translocate,
hence no boundary conditions are employed.
3. Experiments and simulations. We perform three numerical experiments
that exhibit the dynamics and the combination of the two cancer cell phenotypes and
the transitions between the continuum and particle phases. For the sake of simplicity,
we consider a constant diffusion coefficient \sigma in (2.7a) for the random part of the cell
motion, and a drift coefficient \mu depending on the gradient of the ECM, i.e., \mu = \alpha \nabla v,
to address the directed part of their motion.
4Note that \scrR EMT\tau n acts on the EC density, and \scrR MET\tau n acts on the MC cell-particles.
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Table 1
Parameters and units corresponding to Experiment 3.1 and Figure 5.
Description Symbol Values and units
EC dens. diff. coef. D\alpha 0 cm2d - 1
EC dens. prol. coef. \rho \alpha 0 d - 1
MC part. diff. coef. | B| 1.6 cm2d - 1
MC part. hapt. coef. 30 cm3mol - 1d - 1
MC part. ref. mass mref 1\times 10 - 5 gr
MC part. ref. diam. 1\times 10 - 2 cm
EMT prob. 5\times 10 - 4
EMT rate \mu a 1\times 103
MET prob. 0
MMP diff. coef. Dm 0
ECM EC dens. degr. \lambda \alpha v 0 cm
2mol - 1d - 1
ECM MC dens. degr. \lambda \beta v 0 cm
2mol - 1d - 1
The discretization grids used for the numerical solution and simulations of (2.39)
should not be confused with the partitioning of \Omega in \{ Mi, i \in I\} , as in (2.11). The
former are used to solve the system (2.1a)--(2.1c) and are subject to mesh refinements.
The latter are used for the back-and-forth transitions between the density and particle
phases of the biological cells and are fixed, with sizes given that are equivalent to the
reference cell K0.
The implementations of numerical schemes and algorithms, and the simulations
of the experiments included in this paper, have been conducted in MATLAB (2015).
Experiment 3.1 (EMT and particle flow). We set \Omega = [ - 1, 1]2 and consider the
initial EC density,
(3.1a) c\alpha (x, 0) =
\Bigl( 
e - 5(x
2
1+x
2
2)  - 0.7
\Bigr) +
,
with x = (x1, x2) \in \Omega , where (\cdot )+ denotes the positive part function. The ECM is
nonuniform and exhibits a gradient towards the upper-right part of the domain,
(3.1b) v(x, 0) = 0.045 (2x1 + 3x2) + 0.45.
Initially, no MC cell-particles nor MMPs are present.
The parameters for this experiment are given in Table 1, and the results of the
simulation are shown in Figure 5. There is no particular biological justification for
the parameter values and initial conditions in this experiment.
The phenomena observed in this experiment are the following: The ECs undergo
EMT to MCs and new cell-particles appear in the system. The cell-particles ``sense""
the gradient of the ECM and respond haptotactically to it. This is included in the
model and simulations via the advection velocities v of the cell-particles; see, e.g.,
(2.9). Their motion incorporates also a random component; the resulting migration
is a biased-random motion. The simplified EMT that we assume in this experiment
takes place in every partition cell Ki, i \in I with a probability that is denoted as
``EMT prob."" in Table 1. The set union of all partition cells where EMT takes place
defines the set \scrE that appears in (2.1a). The rate \mu a at which the EMT occurs in \scrE is
a given constant. In this experiment, we do not assume proliferation of the ECs nor
MET. Hence, the losses of the EC density due to the EMT appear as ``holes"" in their
density profile and are not replenished with time. Moreover, the ECs do not actively
migrate or otherwise translocate, as (2.1a) includes neither haptotaxis nor diffusion
(set D\alpha = 0 in this experiment); see Table 1.
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(a) t = 0.01 (b) t = 0.06 (c) t = 0.10
(d) t = 0.40 (e) t = 0.85 (f) colorbars
Fig. 5. Experiment 3.1 (EMT and flow). Shown here is the time evolution of an initial EC
density (isolines) and the resulting (after EMT) MC cell-particles (stars) over an ECM (background)
that exhibits a directed gradient. The domain is \Omega = [ - 1, 1]2. (a) An initial circular EC tumor
resides over an ECM that exhibits a gradient towards the northeast direction. (b) The EC density
undergoes EMT and gives rise to MC cell-particles. (c) Due to the diffusion and the haptotaxis, the
cell-particles escape the initial tumor and migrate along the gradient of the ECM. (d) No proliferation
is assumed for the ECs, hence the losses of their densities, due to the EMT towards MCs, are not
replenished. This gives rise to ``holes"" in the initial tumor. (e) The phenomenon continues as
long as parts of the EC density transform into MC cell-particles. (f) Common colorbars for the
ECM (left) and the EC densities (right) in all subfigures. See Table 1 for the parameters for this
experiment.
Experiment 3.2 (self-generated gradient). A typical phenomenon that macro-
scopic cancer invasion models exhibit is the appearance of a propagating front that
invades the ECM faster than the rest of the tumor; see, e.g., Byrne et al. (1999),
Chaplain and Lolas (2005), Sfakianakis et al. (2017). This front is followed by an
intermediate distribution of the density, whereas the bulk of the tumor lags further
behind. This phenomenon is due primarily to the degradation of either an extracellu-
lar chemical (in the case of a self-generated chemical gradient) or the ECM (in the case
of a self-generated haptotaxis gradient) by the cancer cells. Such phenomena have
been observed previously in both mathematical models and biological experiments;
see, e.g., Tweedy et al. (2016), Anderson et al. (2000).
In this experiment we exhibit the ability of our cell-particle submodel to reproduce
such phenomena. In particular, we show that as the cancer cells (considered here
as cell-particles) degrade the ECM, they induce a gradient on it and subsequently
respond to this gradient by performing a directed and sustainable invasion. Most
notably they form an isolated propagating front that invades the ECM.
For this experiment we consider the domain \Omega = [ - 0.5, 0.5] \times [0, 2], over which
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Table 2
Parameters and units corresponding to Experiment 3.2 and Figure 6.
Description Symbol Values and units
EC dens. diff. coef. D\alpha 0 cm2d - 1
EC dens. prol. coef. \rho \alpha 0 d - 1
MC part. diff. coef. | B| 2\times 10 - 2 cm2d - 1
MC part. hapt. coef. 1\times 10 - 3 cm3mol - 1d - 1
MC part. ref. mass mref 3\times 10 - 9 gr
MC part. ref. diam. 1\times 10 - 3 cm
EMT prob. 1
EMT rate \mu a 10
MET prob. 0
MMP diff. coef. Dm 0
ECM EC dens. degr. \lambda \alpha v 20 cm
2mol - 1d - 1
ECM MC dens. degr. \lambda \beta v 200 cm
2mol - 1d - 1
lies a uniform ECM,
(3.2) v(x, 0) = 0.1, x \in \Omega .
On the upper part of the domain, an initial EC density is assumed to be given by
(3.3) c\alpha (x, 0) = 10 - 4\scrX S1(x) , x \in \Omega ,
with S1 =
\bigl\{ 
x = (x1, x2) \in \Omega 
\bigm| \bigm| x2 > 0.01 sin(5\pi x1) + 1.97\bigr\} . Before the simulation be-
gins, the EC density c\alpha (x, 0) is completely transformed into MC cell-particles. As no
MET takes place in this experiment, the MC cell-particles do not transition back to
ECs. The MCs secrete MMPs that participate in the degradation of the ECM. The
corresponding modelling parameters are given in Table 2 and the simulation results
in Figure 6.
In view of (2.8), all cell-particles perform a biased random motion; since the ECM
is initially uniform, this motion is purely Brownian. As the cell-particles degrade the
ECM, a gradient is formed in the matrix. The cell-particles found closer to this
``interface"" sense the gradient and respond haptotactically to it. This is encoded
in the model through the dependence of the advection operator A on the particle
velocity v, e.g., (2.9), which in turn depends on the gradient of the ECM at the
current position of the particle. The directed part of their motion dominates and
drives the cell-particles to higher matrix densities. As the cell-particles continue their
invasion of the ECM they keep producing MMPs, degrading the ECM and following
the newly created gradient. Their motion is persistent in direction and speed.
With our model, we can now address particular questions of experimental interest:
What is the minimum number of cancer cells needed to induce and sustain an invasion
of the ECM persistent in direction and speed? How does the remodelling of the matrix
affect the self-generated gradient motion? Such questions among others, would, serve
as a bridge between experimental observations and mathematical models. Their study
will be the topic of a follow-up work, where the relevant experimental data should be
analysed, as was done, for example, in Yang et al. (2016).
Experiment 3.3 (ECM invasion). This experiment is motivated by the organ-
otypic invasion assays, where cancer cells are plated over a collagen gel that contains
healthy tissue, and where their invasion is studied over time; see, for example, Nystr\"om
et al. (2005), Valster et al. (2005), and Figure 7.
We employ the complete set of dynamics of the system and consider the domain
\Omega = [ - 2, 2]2 occupied by an ECM of initial density v(x, 0) constructed by 64 randomly
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(a) t = 1 (b) t = 40 (c) t = 90
(d) t = 130 (e) t = 180 (f) t = 230
Fig. 6. Experiment 3.2 (self-generated gradient). Shown here is the migration of a number of
MC cell-particles (stars) over an ECM (background landscape) in the absence of MET and EMT.
The directed migration of the MC cell-particles is due to their haptotactic response to the gradients
of the ECM that the MC cell-particles have induced. The domain is \Omega = [ - 0.5, 0.5] \times [0, 2]. (a)
The MC cell-particles reside over an initially uniform ECM. Their migration is mostly Brownian.
(b)--(c) The cell-particles degrade the matrix and introduce a gradient which is sensed by the cell-
particles that are closer to the ``interface."" In effect, their motion is driven mostly by haptotaxis. As
the cells invade the ECM, they continue to degrade the matrix and follow the new gradient that they
have induced. (d)--(f) The migration of the cell-particles in the front is persistent in direction and
speed, while the cell-particles in the rear (where the ECM is depleted) perform mostly a Brownian
motion.
chosen extremal values per direction, interpolated in a piecewise linear way. Small
perturbations of the form of additive Gaussian noise are also included.
An initial density of ECs is given in the upper part of the domain as
(3.4) c\alpha (x, 0) = 0.05\scrX S2(x) , x \in \Omega ,
with S2(x) =
\bigl\{ 
x = (x1, x2) \in \Omega 
\bigm| \bigm| x2 > 0.05 sin(5\pi x1) + 0.05x1 + 1.1\bigr\} . Initially, nei-
ther MC cell-particles nor MMPs exist in the system. The parameters for this ex-
periment can be found in Table 3, and the simulation results are presented in Figure
8.
The ECs proliferate and diffuse, but most notably transform via EMT into MC
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Fig. 7. Timecourse (days 3, 9, and 14) study of the invasion of squamus carcinoma cells (black
matter) on an organotypic assay with human fibroblast cells (gray matter). The invasion occurs in
the form of cancer cell ``islands"" formed in front of the main body of the tumor. We reproduce the
same phenomenon in the invasion Experiment 3.3 and in Figure 8. These images are taken from
Nystr\"om et al. (2005).
Table 3
Parameters, units, and sources corresponding to Experiment 3.3 and Figure 8.
Description Symbol Values and units Sources
EC dens. diff. coef. D\alpha 3.456\times 10 - 6 cm2d - 1 Chaplain and Lolas (2005)
EC dens. prol. coef. \rho \alpha 1.2 d - 1 Orme and Chaplain (1997)
MC part. diff. coef. | B| 3\times 10 - 1 cm2d - 1 Stokes and Lauffenburger
(1998)
MC part. hapt. coef. 3 cm3mol - 1d - 1 (estimate)
MC part. ref. mass mref 3\times 10 - 9 gr B10NUMB3R5 (HeLa cell)
MC part. ref. diam. 1\times 10 - 3 cm B10NUMB3R5 (HeLa cell) \&
Zhao et al. (2008)
EMT prob. 1\times 10 - 5 (estimate)
EMT rate \mu a 4\times 10 - 3 (estimate)
MET prob. 2\times 10 - 2 (estimate)
MMP diff. coef. Dm 0
ECM EC dens. degr. \lambda \alpha v 1\times 10 - 5 cm2mol - 1d - 1 Anderson and Chaplain
(1998)
ECM MC dens. degr. \lambda \beta v 1\times 10 - 4 cm2mol - 1d - 1 Anderson and Chaplain
(1998)
cell-particles. These MC cell-particles do not proliferate, but they are very aggressive
in their motility. As they escape the main body of the tumor, they undergo MET back
to ECs. As a result, new EC concentrations appear, they grow due to proliferation,
and give rise to tumor ``islands."" These ``islands"" merge with each other as well as
with the main body of the tumor. The main characteristic and novelty of our hybrid
model, is that it predicts the emergence of these tumor ``islands"" outside of the main
body of the tumor.
The growth of the tumor with the combined dynamics of the ECs and MCs
possesses several interesting properties. The tumor grows much faster than it would
if it was comprised only of the ECs. This is because the new EC ``islands"" that
arise after the MCs have escaped the main body of the tumor undergo MET, exploit
uninhabited locations, and grow ``to all directions."" On the contrary, in the main
body of the tumor, only the ECs found in the periphery contribute to the growth of
its support.
Moreover, the independent and aggressive migration of MCs provides them with
faster access to the circulatory network and the possibility to translocate to secondary
places within the organism. As the MCs possess the ability to give rise to EC ``islands""
at the new locations, new tumors might appear, and metastasis will have occurred.
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(a) t = 1 (b) t = 150 (c) t = 200
(d) t = 270 (e) t = 330 (f) colorbars
Fig. 8. Experiment 3.3 (ECM invasion). Shown here is the time evolution of the ECM (back-
ground landscape), the EC (isolines), and the MC cell-particles (stars) over the domain \Omega = [ - 2, 2]2.
(a) According to their modelling dynamics, an initial uniform density of ECs evolves according to
system (2.1a)--(2.1c), and mostly proliferates rather than diffuses. (b)--(c) The MC cell-particles
that are produced through the EMT escape the main body of the tumor, invade the ECM, undergo
MET, and eventually give rise to new EC ``islands."" (d)--(e) These ``islands"" grow mostly due to
proliferation and eventually merge with the main body of the tumor. (f) The colorbars for the ECM
(left) and the EC density (right) are common to all figures.
Although it is not our aim in the current paper to reproduce particular experimental
scenarios, a direct comparison of the simulation results in Figure 8 with the organ-
otypic assay images in Figure 7 exhibits clearly that this phenomenon is reproduced
by our model.
Another sought-after property in cancer invasion modelling is that the MCs re-
main undetected while they invade the ECM. It is not until a new ECs tumor has been
established that it can grow to a detectable size. Again, this property is inherently
built into our modelling approach.
4. Discussion. In this work, we present a modelling framework to study the
combined invasion of the ECM by two types of cancer cells, the ECs and MCs. The
proposed framework is a genuinely multiscale hybrid model that treats the ECs in a
macroscopic and deterministic manner, and the MCs in an atomistic and stochastic
way. It has similarities with and develops further along the lines of, e.g., Anderson
et al. (2000), Anderson (2005), Colombi, Scianna, and Preziosi (2017).
The cornerstone of our modelling approach is the notion that the MCs are far
fewer than the ECs, and that they emanate from the ECs via a dynamic EMT cellular
differentiation program. We also assume that the MCs give rise, via the opposite
MET-like cellular program, to ECs; a key property in the metastasis of the tumor.
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For the sake of simplicity, we assume that both types of cancer cells perform a random
motion, and that the MCs are much more aggressive in their migration than the ECs.
Clearly, more complex and biologically relevant assumptions can be placed on the
cancer cells.
We encode this information through a hybrid approach: The spatiotemporal evo-
lution of the ECs, the ECM, the MMPs, and the rest of the environmental components
is dictated by the macroscopic deterministic model (2.1a)--(2.1c). Namely, the ECs
are assumed to diffuse and proliferate. The MMPs are assumed to be produced by
the cancer cells and degrade the ECM, and the ECM in turn is assumed to be non-
uniform and is not remodelled. The MCs on the other hand are considered as separate
cell-particles that obey a system of SDEs, (2.7a), that accounts for haptotaxis and
random motion for each MC.
The (combined) evolution of the two types of cancer cells is coupled through
transitions between the EMT and MET. The triggering mechanisms of EMT and
MET are quite complex and involve the action of several biochemical components
such as TGF-\beta , EGF, and more. For clarity of the presentation, we follow in this
work a simplified approach and assume that the EMT and MET occur randomly
over the ECs and MCs, respectively; cf. section 2.4. The EMT and MET programs
are realized through the density-to-particle and particle-to-density operators given in
(2.17) and (2.21).
Our modelling approach allows one to reproduce several biologically relevant phe-
nomena encountered in the invasion of cancer that are not easily addressed with the
usual modelling approaches. Our focus in this work, though, lies with the description
and the handling of the mathematical model and the numerical method; we only pres-
ent here basic biological situations and postpone the more elaborate investigations for
a follow-up work.
With the atomistic component of our model, we are able to reproduce a sustain-
able invasion of the ECM by means of a self-induced haptotaxis gradient, as shown
in Experiment 3.2. Such behavior is observed in biological situations, e.g., Tweedy
et al. (2016), and becomes crucial to several biological processes like wound healing.
The detailed study of such cases falls beyond the scope of the current paper; here we
use this experiment as an indication that our model can reproduce biologically rele-
vant situations. At the same time it serves as verification of the propagating invasion
front seen in simulations of macroscopic deterministic cancer invasion models, e.g.,
Anderson and Chaplain (1998), Chaplain and Lolas (2005), Sfakianakis et al. (2017).
With the full model, we are able to reproduce the spread of the tumor and the
invasion of the ECM in the form of invasion ``islands,"" e.g., Japanese Gastric Can-
cer Association (2011), Ito et al. (2012), Masuda et al. (2017), and Experiment 3.3.
These are well known to appear in many cases of cancer and are quite challenging to
reproduce by macroscopic or atomistic cancer invasion models, e.g., Domschke et al.
(2014b), Hiremath and Surulescu (2016b). With our approach these invasion ``islands""
are an emergent process of our modelling framework and---most notably---they appear
outside the main body of the tumor.
What is also inherent in our approach is that the MC cell-particles escape the
main body of the tumor and remain undetected while they invade the ECM. It is
only after they have established new ``islands"" in the vicinity of the original tumor or
in another location within the organism that they can be detected. This is another
sought-after property in the field of cancer invasion modelling.
To simplify presentation, we have only considered here some of the fundamental
properties of cancer growth that our model can reproduce; see (2.1a)--(2.1c). Still they
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warrant extensions to and investigations of more realistic biological situations and
experimental settings. To mention but a few: extension to the more realistic three-
dimensional space, more realistic EMT and MET transitions, interactions between
cancer cells of the same and different types including collisions, adhesions, short or
long range interactions, and the collective behavior of cancer cells.
Data management. All of the computational data output is included in the
present manuscript.
Supplementary material. Two simulations that correspond to Experiments
3.2 and 3.3, i.e., Self generated gradient and ECM invasion, respectively, can be
found in the supplementary material.
Appendix A. Numerical method for the model (2.2). We use a sec-
ond order Implicit-Explicit Runge--Kutta (IMEX-RK) Finite Volume (FV) numeri-
cal method that was previously developed in Kolbe et al. (2016), Sfakianakis et al.
(2017), to which we refer the reader for more details; see also Lakkis, Madzvamuse,
and Venkataraman (2012). Here we provide some basic description of the method.
We consider a generic Advection-Reaction Diffusion system of the form
(A.1) wt = A(w) +R(w) +D(w),
where w represents the solution vector, and A, R, and D the advection, reaction, and
diffusion operators, respectively.
We denote bywh(t) the corresponding (semi-)discrete numerical approximation---
indexed here by the maximal spatial grid diameter h---that satisfies the system of
ODEs
(A.2) \partial twh = \scrA (wh) +\scrR (wh) +\scrD (wh),
where the numerical operators \scrA , \scrR , and \scrD are discrete approximations of the oper-
ators A, R, and D in (A.1), respectively.
Our method of choice for solving (A.2) is an IMEX-RKmethod based on a splitting
in explicit and implicit terms in the form
(A.3) \partial twh = \scrI (wh) + \scrE (wh).
The actual splitting depends on the particular problem at hand, but in a typical case,
the advection terms \scrA are treated explicitly in time, the diffusion terms \scrD implicitly,
and the reaction terms \scrR both explicitly and implicitly.
More precisely, we employ a diagonally implicit RK method for the implicit part,
and an explicit RK for the explicit part,
(A.4)
\left\{                         
W\ast i = w
n
h + \tau n
i - 2\sum 
j=1
\=ai,jEj + \tau n\=ai,i - 1Ei - 1, i = 1, . . . , s,
Wi =W
\ast 
i + \tau n
i - 1\sum 
j=1
ai,jIj + \tau nai,iIi, i = 1, . . . , s,
wn+1h = w
n
h + \tau n
s\sum 
i=1
\=biEi + \tau n
s\sum 
i=1
biIi,
where s = 4 are the stages of the IMEX method, and Ei = \scrE (Wi), Ii = \scrI (Wi),
i = 1, . . . , s, \{ \=b, \=A\} , \{ b, A\} are, respectively, the coefficients for the explicit and the
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Table 4
Butcher tableaux for the explicit (upper) and the implicit (lower) parts of the third order IMEX
scheme (A.4); see also Kennedy and Carpenter (2003).
0
1767732205903
2027836641118
1767732205903
2027836641118
3
5
5535828885825
10492691773637
788022342437
10882634858940
1 6485989280629
16251701735622
 - 4246266847089
9704473918619
10755448449292
10357097424841
1471266399579
7840856788654
 - 4482444167858
7529755066697
11266239266428
11593286722821
1767732205903
4055673282236
0 0
1767732205903
2027836641118
1767732205903
4055673282236
1767732205903
4055673282236
3
5
2746238789719
10658868560708
 - 640167445237
6845629431997
1767732205903
4055673282236
1 1471266399579
7840856788654
 - 4482444167858
7529755066697
11266239266428
11593286722821
1767732205903
4055673282236
1471266399579
7840856788654
 - 4482444167858
7529755066697
11266239266428
11593286722821
1767732205903
4055673282236
implicit part of the scheme, given by the Butcher tableau in Table 4, e.g., Kennedy and
Carpenter (2003). We solve the linear systems in (A.4) using the iterative biconjugate
gradient stabilized Krylov subspace method, e.g., Krylov (1931), van der Vorst (1992).
Appendix B. An explicit numerical scheme for the SDE (2.7a). We
consider an Ito process X = \{ Xt, t0 \leq t \leq T\} that satisfies the Brownian motion
SDE,
(B.1) dXt = \alpha Xtdt+ \beta dWt,
where Xt denotes the position in space, and where \alpha \in \BbbR and \beta > 0 are constants.
We discretize (B.1) with the explicit Euler--Maruyama scheme:
(B.2) Xn+1 = Xn + \alpha Xn\tau + \beta \Delta Wt.
By setting \Delta Wt = Z
\surd 
\tau with Z \sim N(0, 1), (B.2) reads
(B.3) Xn+1 = Xn + \alpha Xn\tau + \beta Z
\surd 
\tau ,
which is a simpler version of the scheme that we employ in (2.8).
For further details on the numerical treatment of (B.1) and other SDEs, we refer
the reader to Iacus (2008) and Kloeden and Platen (1992).
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